CN100569282C - 注射用骨肽冻干剂及其制备方法 - Google Patents
注射用骨肽冻干剂及其制备方法 Download PDFInfo
- Publication number
- CN100569282C CN100569282C CNB200610150890XA CN200610150890A CN100569282C CN 100569282 C CN100569282 C CN 100569282C CN B200610150890X A CNB200610150890X A CN B200610150890XA CN 200610150890 A CN200610150890 A CN 200610150890A CN 100569282 C CN100569282 C CN 100569282C
- Authority
- CN
- China
- Prior art keywords
- preparation
- hours
- bone peptide
- injection
- jacketed pan
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 210000000988 bone and bone Anatomy 0.000 title claims abstract description 81
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 59
- 238000002347 injection Methods 0.000 title claims abstract description 24
- 239000007924 injection Substances 0.000 title claims abstract description 24
- 238000002360 preparation method Methods 0.000 title claims abstract description 22
- 238000004108 freeze drying Methods 0.000 title claims abstract description 16
- 239000002274 desiccant Substances 0.000 title claims abstract description 13
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims abstract description 90
- 239000000243 solution Substances 0.000 claims abstract description 44
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 29
- 239000006228 supernatant Substances 0.000 claims abstract description 22
- 239000004744 fabric Substances 0.000 claims abstract description 21
- 238000004140 cleaning Methods 0.000 claims abstract description 11
- 230000007062 hydrolysis Effects 0.000 claims abstract description 11
- 238000006460 hydrolysis reaction Methods 0.000 claims abstract description 11
- 239000008213 purified water Substances 0.000 claims abstract description 11
- 239000000047 product Substances 0.000 claims abstract description 7
- 239000002994 raw material Substances 0.000 claims abstract description 7
- 239000007788 liquid Substances 0.000 claims description 50
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 38
- 238000001914 filtration Methods 0.000 claims description 34
- 238000005303 weighing Methods 0.000 claims description 20
- 229910052799 carbon Inorganic materials 0.000 claims description 19
- 238000003756 stirring Methods 0.000 claims description 19
- 239000012982 microporous membrane Substances 0.000 claims description 14
- 239000003814 drug Substances 0.000 claims description 12
- 238000007689 inspection Methods 0.000 claims description 12
- 239000008215 water for injection Substances 0.000 claims description 12
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 11
- 239000000706 filtrate Substances 0.000 claims description 10
- 239000012530 fluid Substances 0.000 claims description 10
- 238000000108 ultra-filtration Methods 0.000 claims description 10
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 9
- 238000010792 warming Methods 0.000 claims description 9
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 5
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical group OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 5
- 229920002307 Dextran Polymers 0.000 claims description 5
- 229930195725 Mannitol Natural products 0.000 claims description 5
- 239000000594 mannitol Substances 0.000 claims description 5
- 235000010355 mannitol Nutrition 0.000 claims description 5
- 229920001184 polypeptide Polymers 0.000 claims description 5
- 239000000600 sorbitol Substances 0.000 claims description 5
- 230000008901 benefit Effects 0.000 claims description 4
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 claims description 3
- 210000004907 gland Anatomy 0.000 claims description 3
- FZWBNHMXJMCXLU-BLAUPYHCSA-N isomaltotriose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)O1 FZWBNHMXJMCXLU-BLAUPYHCSA-N 0.000 claims description 3
- 238000011068 loading method Methods 0.000 claims description 3
- 238000005259 measurement Methods 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 abstract description 7
- 230000002052 anaphylactic effect Effects 0.000 abstract description 3
- 238000000605 extraction Methods 0.000 abstract description 2
- 239000000825 pharmaceutical preparation Substances 0.000 abstract description 2
- 239000002510 pyrogen Substances 0.000 abstract description 2
- 238000005516 engineering process Methods 0.000 description 7
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 6
- 229910052782 aluminium Inorganic materials 0.000 description 6
- 239000004411 aluminium Substances 0.000 description 6
- 239000011521 glass Substances 0.000 description 6
- 239000012528 membrane Substances 0.000 description 6
- 238000000465 moulding Methods 0.000 description 6
- 230000000694 effects Effects 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 229920000642 polymer Polymers 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 241000283898 Ovis Species 0.000 description 2
- 241000282894 Sus scrofa domesticus Species 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 150000003384 small molecules Chemical class 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 241000282898 Sus scrofa Species 0.000 description 1
- 230000004097 bone metabolism Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000011164 ossification Effects 0.000 description 1
- 210000000963 osteoblast Anatomy 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Description
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB200610150890XA CN100569282C (zh) | 2006-10-13 | 2006-10-13 | 注射用骨肽冻干剂及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB200610150890XA CN100569282C (zh) | 2006-10-13 | 2006-10-13 | 注射用骨肽冻干剂及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1939342A CN1939342A (zh) | 2007-04-04 |
CN100569282C true CN100569282C (zh) | 2009-12-16 |
Family
ID=37958044
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB200610150890XA Active CN100569282C (zh) | 2006-10-13 | 2006-10-13 | 注射用骨肽冻干剂及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100569282C (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9763993B2 (en) | 2015-01-28 | 2017-09-19 | Teva Pharmaceutical Industries Ltd. | Process for manufacturing glatiramer acetate product |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100457178C (zh) * | 2007-05-25 | 2009-02-04 | 黑龙江省珍宝岛制药有限公司 | 一种骨肽注射剂的制备方法 |
CN100525833C (zh) * | 2007-09-21 | 2009-08-12 | 南京大学 | 右旋糖苷40/多肽冻干粉针剂成型的方法 |
CN102188692B (zh) * | 2011-04-29 | 2012-08-08 | 俞嘉林 | 一种骨肽组合物及其制剂、制备方法和应用 |
CN102212109B (zh) * | 2011-04-29 | 2012-08-29 | 俞嘉林 | 从骨肽注射剂中分离的骨多肽化合物及其应用 |
-
2006
- 2006-10-13 CN CNB200610150890XA patent/CN100569282C/zh active Active
Non-Patent Citations (2)
Title |
---|
中药药剂学. 范碧亭,225-226,上海科学技术出版社. 1997 |
中药药剂学. 范碧亭,225-226,上海科学技术出版社. 1997 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9763993B2 (en) | 2015-01-28 | 2017-09-19 | Teva Pharmaceutical Industries Ltd. | Process for manufacturing glatiramer acetate product |
Also Published As
Publication number | Publication date |
---|---|
CN1939342A (zh) | 2007-04-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100569282C (zh) | 注射用骨肽冻干剂及其制备方法 | |
CN105936927B (zh) | 一种核桃低聚肽及其制备工艺和用途 | |
US10988638B2 (en) | Process to reduce endotoxin in gelatin | |
CN102188692B (zh) | 一种骨肽组合物及其制剂、制备方法和应用 | |
CN101628025B (zh) | 包含鹿骨提取物和甜瓜籽提取物的药物组合物 | |
KR100383798B1 (ko) | 실크 펩타이드를 함유하는 기능성 음료의 제조방법 | |
CN100579574C (zh) | 注射用脑蛋白水解物冻干剂制备方法 | |
CN1939343B (zh) | 骨肽氯化钠注射液及其制备工艺 | |
CN100457178C (zh) | 一种骨肽注射剂的制备方法 | |
CN1166669C (zh) | 斑蝥酸钠的制备工艺 | |
CN108178782A (zh) | 一种鲻鱼鱼鳞铁螯合肽的用途 | |
CN1939533B (zh) | 注射用肌氨肽苷粉针剂及其制备方法 | |
CN103845722A (zh) | 一种防治辐射损伤或化学药物治疗损伤的低聚肽组合物及其制备方法 | |
CN107988302B (zh) | 一种鹿瓜多肽的制备方法及鹿瓜多肽在制备特殊医学用途食品中的应用 | |
CN101940596A (zh) | 一种新的制备脑蛋白水解物的方法 | |
CN103041366B (zh) | 一种骨肽组合物及其制备方法 | |
CN108969538A (zh) | 一种鹿茸含片及其衍生鹿茸多肽的生产工艺 | |
KR20110017553A (ko) | 인슐린 유사 성장인자 분비 및 뼈 골격 성장 촉진용 백하수오 추출물과 속단 추출물 및 그 제조방법 | |
CN101732697B (zh) | 一种复方骨肽冻干制剂 | |
CN109432043B (zh) | 医用桑蛋白胶囊壳及其制备方法 | |
CN1935201B (zh) | 附子提取物及其制备方法 | |
CN1230175C (zh) | 注射用盐酸川芎嗪冻干剂及其制备方法 | |
CN102212106A (zh) | 一种以哺乳动物四肢骨制备骨肽的生产工艺 | |
CN107793495A (zh) | 皱皮木瓜多糖及其制备方法和应用 | |
CN106222223B (zh) | 人血白蛋白的生产方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Assignee: Medisan Pharmaceutical Co., Ltd., Harbin Assignor: Yu Jialin Contract record no.: 2012230000477 Denomination of invention: Injection bone peptide freeze-drying preparation and its making method Granted publication date: 20091216 License type: Exclusive License Open date: 20070404 Record date: 20120529 |
|
EM01 | Change of recordation of patent licensing contract |
Change date: 20140516 Contract record no.: 2012230000477 Assignee after: MEDISAN PHARMACEUTICAL CO., LTD. HARBIN Assignee before: Medisan Pharmaceutical Co., Ltd., Harbin |
|
LICC | Enforcement, change and cancellation of record of contracts on the licence for exploitation of a patent or utility model | ||
EM01 | Change of recordation of patent licensing contract |
Change date: 20140516 Contract record no.: 2012230000477 Assignee after: MEDISAN PHARMACEUTICAL CO., LTD. HARBIN Assignee before: Medisan Pharmaceutical Co., Ltd., Harbin |
|
LICC | Enforcement, change and cancellation of record of contracts on the licence for exploitation of a patent or utility model | ||
EC01 | Cancellation of recordation of patent licensing contract | ||
EC01 | Cancellation of recordation of patent licensing contract |
Assignee: MEDISAN PHARMACEUTICAL CO., LTD. HARBIN Assignor: Yu Jialin Contract record no.: 2012230000477 Date of cancellation: 20170503 |
|
EE01 | Entry into force of recordation of patent licensing contract | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20070404 Assignee: MEDISAN PHARMACEUTICAL CO., LTD. HARBIN Assignor: Yu Jialin Contract record no.: 2017230000015 Denomination of invention: Injection bone peptide freeze-drying preparation and its making method Granted publication date: 20091216 License type: Exclusive License Record date: 20161009 |
|
TR01 | Transfer of patent right |
Effective date of registration: 20190524 Address after: 150000 Beijing Road, Limin Development Zone, Harbin, Heilongjiang Province Patentee after: MEDISAN PHARMACEUTICAL CO., LTD. HARBIN Address before: Room 615, 162 Hongqi Street, Nangang District, Harbin City, Heilongjiang Province, 150090 Patentee before: Yu Jialin |
|
TR01 | Transfer of patent right |